A cell-penetrating helical polymer for siRNA delivery to mammalian cells

Molecular Therapy

Volumn 20, Issue 8, 2012, Pages 1599-1609

  Gabrielson, Nathan P ^a   Lu, Hua ^b   Yin, Lichen ^c   Kim, Kyung Hoon ^c   Cheng, Jianjun ^a,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c University of Illinois at Urbana Champaign   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; POLYMER; POLY[GAMMA (4 VINYLBENZYL)GLUTAMATE]; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL VIABILITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOSOLIC FRACTION; CYTOTOXICITY TEST; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; MEMBRANE DAMAGE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PH MEASUREMENT; POROSITY;

MAMMALIA;

EID: 84864557436     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.78     Document Type: Article

References (34)

1. Buckley, RH (2002). Gene therapy for SCID-a complication after remarkable progress. Lancet 360: 1185-1186.
2. Hollon, T (2000). Researchers and regulators reflect on first gene therapy death. Nat Med 6: 6.
3. Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE and Mello, CC (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
4. Dykxhoorn, DM and Lieberman, J (2006). Knocking down disease with siRNAs. Cell 126: 231-235.
5. Whitehead, KA, Langer, R and Anderson, DG (2009). Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138.
6. Akhtar, S and Benter, IF (2007). Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 117: 3623-3632.
7. Paroo, Z and Corey, DR (2004). Challenges for RNAi in vivo. Trends Biotechnol 22: 390-394.
8. Akinc, A, Zumbuehl, A, Goldberg, M, Leshchiner, ES, Busini, V, Hossain, N et al. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26: 561-569.
9. Wu, SY and McMillan, NA (2009). Lipidic systems for in vivo siRNA delivery. AAPS J 11: 639-652.
10. Davis, ME (2009). The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6: 659-668.
11. Song, E, Zhu, P, Lee, SK, Chowdhury, D, Kussman, S, Dykxhoorn, DM et al. (2005). Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23: 709-717.
12. Crombez, L, Aldrian-Herrada, G, Konate, K, Nguyen, QN, McMaster, GK, Brasseur, R et al. (2009). A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther 17: 95-103.
13. McNamara, JO 2nd, Andrechek, ER, Wang, Y, Viles, KD, Rempel, RE, Gilboa, E et al. (2006). Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24: 1005-1015.
14. Zhou, J, Li, H, Li, S, Zaia, J and Rossi, JJ (2008). Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther 16: 1481-1489.
15. Soutschek, J, Akinc, A, Bramlage, B, Charisse, K, Constien, R, Donoghue, M et al. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178.
16. Rozema, DB, Lewis, DL, Wakefield, DH, Wong, SC, Klein, JJ, Roesch, PL et al. (2007). Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 104: 12982-12987.
17. Svintradze, DV and Mrevlishvili, GM (2005). Fiber molecular model of atelocollagensmall interfering RNA (siRNA) complex. Int J Biol Macromol 37: 283-286.
18. Dominska, M and Dykxhoorn, DM (2010). Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci 123(Pt 8): 1183-1189.
19. Davidson, TJ, Harel, S, Arboleda, VA, Prunell, GF, Shelanski, ML, Greene, LA et al. (2004). Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J Neurosci 24: 10040-10046.
20. Muratovska, A and Eccles, MR (2004). Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett 558: 63-68.
21. Kim, WJ, Christensen, LV, Jo, S, Yockman, JW, Jeong, JH, Kim, YH et al. (2006). Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 14: 343-350.
22. Björklund, J, Biverståhl, H, Gräslund, A, Mäler, L and Brzezinski, P (2006). Realtime transmembrane translocation of penetratin driven by light-generated proton pumping. Biophys J 91: L29-L31.
23. Potocky, TB, Menon, AK and Gellman, SH (2003). Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J Biol Chem 278: 50188-50194.
24. Gabrielson, NP and Pack, DW (2009). Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells. J Control Release 136: 54-61.
25. Lu, JJ, Langer, R and Chen, J (2009). A novel mechanism is involved in cationic lipidmediated functional siRNA delivery. Mol Pharm 6: 763-771.
26. Lu, H, Wang, J, Bai, Y, Lang, JW, Liu, S, Lin, Y et al. (2011). Ionic polypeptides with unusual helical stability. Nat Commun 2: 206.
27. Gabrielson, NP, Lu, H, Yin, L, Li, D, Wang, F and Cheng, J (2012). Reactive and bioactive cationic a-helical polypeptide template for nonviral gene delivery. Angew Chem Int Ed Engl 51: 1143-1147.
28. Lundberg, P, El-Andaloussi, S, Sütlü, T, Johansson, H and Langel, U (2007). Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 21: 2664-2671.
29. Kebbekus, P, Draper, DE and Hagerman, P (1995). Persistence length of RNA. Biochemistry 34: 4354-4357.
30. van der Aa, MA, Huth, US, Häfele, SY, Schubert, R, Oosting, RS, Mastrobattista, E et al. (2007). Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res 24: 1590-1598.
31. Davis, ME, Zuckerman, JE, Choi, CH, Seligson, D, Tolcher, A, Alabi, CA et al. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464: 1067-1070.
32. Li, W, Nicol, F and Szoka, FC Jr (2004). GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 56: 967-985.
33. Wyman, TB, Nicol, F, Zelphati, O, Scaria, PV, Plank, C and Szoka, FC Jr (1997). Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36: 3008-3017.
34. Forrest, ML and Pack, DW (2002). On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Mol Ther 6: 57-66.